Mixed amphetamine salts: Difference between revisions
From Pharmacopedia
More actions
| [checked revision] | [checked revision] |
MDElliottMD (talk | contribs) No edit summary |
MDElliottMD (talk | contribs) No edit summary |
||
| Line 72: | Line 72: | ||
* <effect ref="hyperthermia" author="MDElliottMD">Risk in hot environments or with vigorous exercise.</effect> | * <effect ref="hyperthermia" author="MDElliottMD">Risk in hot environments or with vigorous exercise.</effect> | ||
* <effect ref="withdrawal" author="MDElliottMD">Low motivation, low mood, hypersomnia, increased appetite on abrupt discontinuation.</effect> | * <effect ref="withdrawal" author="MDElliottMD">Low motivation, low mood, hypersomnia, increased appetite on abrupt discontinuation.</effect> | ||
* <effect ref="urinary-retention" author="MDElliottMD">Difficult/slow urination</effect> | * <effect ref="urinary-retention" author="MDElliottMD">Difficult/slow urination</effect> | ||
| pk_absorption = Excellent oral bioavailability — sources report ">75%" to "~90%". Food does not significantly affect total absorption but can delay peak concentration. | | pk_absorption = Excellent oral bioavailability — sources report ">75%" to "~90%". Food does not significantly affect total absorption but can delay peak concentration. | ||
| pk_distribution = Volume of distribution ~4 L/kg; plasma protein binding less than 20%. Crosses the blood–brain barrier and placenta. | | pk_distribution = Volume of distribution ~4 L/kg; plasma protein binding less than 20%. Crosses the blood–brain barrier and placenta. | ||